Literature DB >> 28365630

Thrombolysis and thrombectomy for acute ischaemic stroke.

Salwa El Tawil1, Keith W Muir2.   

Abstract

The likelihood of disability-free recovery after acute ischemic stroke is significantly improved by reperfusion either by intravenous thrombolytic drug treatment or with endovascular mechanical thrombectomy in selected cases. The use of intravenous thrombolysis is limited by the short treatment window and you need to assess individual balance of benefit and risk of symptomatic intracranial haemorrhage. Benefit is greater for shorter onset-to-reperfusion time intervals, requiring optimisation of pre-hospital and in-hospital pathways. Symptomatic haemorrhage is more likely with more severe strokes, but a greater proportion of patients are left free of disability than suffer a treatment-related haemorrhage at all levels of severity. Extracranial haemorrhage and orolingual angioedema are less common complications. Endovascular mechanical thrombectomy can be used in selected patients with imaging-proven large artery occlusion. Successful therapy depends on well-organised services that can deliver treatment within a short time window at centres with adequate expertise to perform the procedure. © Royal College of Physicians 2017. All rights reserved.

Entities:  

Keywords:  Cerebrovascular disease; endovascular treatment; stroke; thrombectomy; thrombolysis

Mesh:

Year:  2017        PMID: 28365630      PMCID: PMC6297620          DOI: 10.7861/clinmedicine.17-2-161

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  29 in total

1.  Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke.

Authors:  G J del Zoppo; K Poeck; M S Pessin; S M Wolpert; A J Furlan; A Ferbert; M J Alberts; J A Zivin; L Wechsler; O Busse
Journal:  Ann Neurol       Date:  1992-07       Impact factor: 10.422

2.  Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.

Authors:  Götz Thomalla; Jan Sobesky; Martin Köhrmann; Jochen B Fiebach; Jens Fiehler; Olivier Zaro Weber; Anna Kruetzelmann; Thomas Kucinski; Michael Rosenkranz; Joachim Röther; Peter D Schellinger
Journal:  Stroke       Date:  2007-01-04       Impact factor: 7.914

Review 3.  Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors.

Authors:  Maarten G Lansberg; Gregory W Albers; Christine A C Wijman
Journal:  Cerebrovasc Dis       Date:  2007-05-22       Impact factor: 2.762

Review 4.  Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association.

Authors:  Richard E Latchaw; Mark J Alberts; Michael H Lev; John J Connors; Robert E Harbaugh; Randall T Higashida; Robert Hobson; Chelsea S Kidwell; Walter J Koroshetz; Vincent Mathews; Pablo Villablanca; Steven Warach; Beverly Walters
Journal:  Stroke       Date:  2009-09-24       Impact factor: 7.914

5.  Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score.

Authors:  Michael Mazya; José A Egido; Gary A Ford; Kennedy R Lees; Robert Mikulik; Danilo Toni; Nils Wahlgren; Niaz Ahmed
Journal:  Stroke       Date:  2012-03-22       Impact factor: 7.914

Review 6.  Advanced multimodal CT/MRI approaches to hyperacute stroke diagnosis, treatment, and monitoring.

Authors:  David S Liebeskind; Andrei V Alexandrov
Journal:  Ann N Y Acad Sci       Date:  2012-09       Impact factor: 5.691

7.  Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study.

Authors:  Andrew M Demchuk; Michael D Hill; Philip A Barber; Brian Silver; Suresh C Patel; Steven R Levine
Journal:  Stroke       Date:  2005-09-15       Impact factor: 7.914

8.  Prehospital and emergency department delays after acute stroke: the Genentech Stroke Presentation Survey.

Authors:  D L Morris; W Rosamond; K Madden; C Schultz; S Hamilton
Journal:  Stroke       Date:  2000-11       Impact factor: 7.914

9.  Guidelines for management of ischaemic stroke and transient ischaemic attack 2008.

Authors: 
Journal:  Cerebrovasc Dis       Date:  2008-05-06       Impact factor: 2.762

10.  The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

Authors:  Peter Sandercock; Joanna M Wardlaw; Richard I Lindley; Martin Dennis; Geoff Cohen; Gordon Murray; Karen Innes; Graham Venables; Anna Czlonkowska; Adam Kobayashi; Stefano Ricci; Veronica Murray; Eivind Berge; Karsten Bruins Slot; Graeme J Hankey; Manuel Correia; Andre Peeters; Karl Matz; Phillippe Lyrer; Gord Gubitz; Stephen J Phillips; Antonio Arauz
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321

View more
  14 in total

1.  Learning to Predict Ischemic Stroke Growth on Acute CT Perfusion Data by Interpolating Low-Dimensional Shape Representations.

Authors:  Christian Lucas; André Kemmling; Nassim Bouteldja; Linda F Aulmann; Amir Madany Mamlouk; Mattias P Heinrich
Journal:  Front Neurol       Date:  2018-11-26       Impact factor: 4.003

2.  Preclinical Validation of the Therapeutic Potential of Glasgow Oxygen Level Dependent (GOLD) Technology: a Theranostic for Acute Stroke.

Authors:  Graeme A Deuchar; Josie C van Kralingen; Lorraine M Work; Celestine Santosh; Keith W Muir; Chris McCabe; I Mhairi Macrae
Journal:  Transl Stroke Res       Date:  2018-11-30       Impact factor: 6.829

3.  SIRT1 Protects Against Apoptosis by Promoting Autophagy in the Oxygen Glucose Deprivation/Reperfusion-Induced Injury.

Authors:  Qiannan Ren; Zhiying Hu; Yuting Jiang; Xiaoning Tan; Benson O A Botchway; Nashwa Amin; Gaoping Lin; Yu Geng; Marong Fang
Journal:  Front Neurol       Date:  2019-12-05       Impact factor: 4.003

4.  YTHDC1 mitigates ischemic stroke by promoting Akt phosphorylation through destabilizing PTEN mRNA.

Authors:  Zhaolong Zhang; Qiuhan Wang; Xiaolong Zhao; Liming Shao; Guoping Liu; Xuan Zheng; Lingling Xie; Yan Zhang; Chengjian Sun; Rui Xu
Journal:  Cell Death Dis       Date:  2020-11-13       Impact factor: 8.469

5.  Early Progressive Changes in White Matter Integrity Are Associated with Stroke Recovery.

Authors:  Daniela Pinter; Thomas Gattringer; Simon Fandler-Höfler; Markus Kneihsl; Sebastian Eppinger; Hannes Deutschmann; Alexander Pichler; Birgit Poltrum; Gernot Reishofer; Stefan Ropele; Reinhold Schmidt; Christian Enzinger
Journal:  Transl Stroke Res       Date:  2020-03-04       Impact factor: 6.829

6.  Impact of hydroxytyrosol on stroke: tracking therapy response on neuroinflammation and cerebrovascular parameters using PET-MR imaging and on functional outcomes.

Authors:  Cristina Barca; Maximilian Wiesmann; Jesús Calahorra; Lydia Wachsmuth; Christian Döring; Claudia Foray; Ali Heiradi; Sven Hermann; Maria Ángeles Peinado; Eva Siles; Cornelius Faber; Michael Schäfers; Amanda J Kiliaan; Andreas H Jacobs; Bastian Zinnhardt
Journal:  Theranostics       Date:  2021-02-15       Impact factor: 11.556

7.  "My life after stroke through a camera lens"- A photovoice study on participation in Sweden.

Authors:  Karin Törnbom; Jörgen Lundälv; Annie Palstam; Katharina S Sunnerhagen
Journal:  PLoS One       Date:  2019-09-11       Impact factor: 3.240

Review 8.  Epigenetic Mechanisms Underlying Adult Post Stroke Neurogenesis.

Authors:  Xianshuang Liu; Baoyan Fan; Michael Chopp; Zhenggang Zhang
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

9.  Automated Cerebral Infarct Detection on Computed Tomography Images Based on Deep Learning.

Authors:  Syu-Jyun Peng; Yu-Wei Chen; Jing-Yu Yang; Kuo-Wei Wang; Jang-Zern Tsai
Journal:  Biomedicines       Date:  2022-01-06

10.  Adverse consequences of immediate thrombolysis-related complications: a multi-centre registry-based cohort study of acute stroke.

Authors:  Thang S Han; Giosue Gulli; Christopher H Fry; Brendan Affley; Jonathan Robin; David Fluck; Puneet Kakar; Pankaj Sharma
Journal:  J Thromb Thrombolysis       Date:  2021-07-13       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.